21st Annual Highlights of the 2022 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this virtual CME is designed to help medical, radiation, and surgical oncologists, gynecologists, radiologists, and primary care physicians translate the data from key presentations from the 2022 San Antonio Breast Cancer Symposium into practice.
Join speakers from Fox Chase and Penn Medicine’s Abramson Cancer Center as they present information on the treatment of breast cancer, including screening, prevention, local control, chemotherapy, hormonal therapy, and advances in breast cancer biologics and their impact on breast cancer management.
VIRTUAL CME: Thursday, January 19, 2023
5–9 pm EST Exhibit Hall Open
6–8:30 pm EST Education Program
8:30–9 pm EST Virtual Q&A Reception & Exhibit Hall
Program Director
Lori J. Goldstein, MD, FASCO
Professor Emerita
Department of Hematology/Oncology
Fox Chase Cancer Center
Fox Chase Cancer Center Faculty
Richard J. Bleicher, MD, FACS
Professor, Department of Surgical Oncology; Leader, Breast Cancer Program; Director, Breast Fellowship Program
Fox Chase Cancer Center
Melissa McShane, MD
Assistant Professor, Department of Hematology/Oncology;
Associate Program Director, Hematology/Oncology Fellowship Training Program
Fox Chase Cancer Center
Saba Shaikh, MD
Assistant Professor, Department of Hematology/Oncology;
Fox Chase Cancer Center
Penn Medicine’s Abramson Cancer Center Faculty
Susan M. Domchek, MD
Executive Director, Basser Center for BRCA;
Director, MacDonald Cancer Risk Evaluation Center;
Basser Professor in Oncology
Fox Chase Cancer Center
Angela DeMichele, MD, MSCE
Jill & Alan Miller Endowed Chair in Breast Cancer Excellence;
Professor of Medicine;
Co-Leader, Breast Cancer Program;
Co-Director, 2-PREVENT Translational Center of Excellence
Fox Chase Cancer Center
Learning Objectives
After attending this program, participants should be able to:
- Analyze the advances in the management of breast cancer and premalignant breast disease and, when clinically relevant, integrate new findings into the management of patients with breast cancer and premalignant breast disease.
- When clinically relevant, apply new strategies for optimizing existing treatments into the management of these patients.
- Analyze new developments in breast cancer research and current available clinical trials and, when clinically relevant, include this information in discussions with patients.
Intended Audience
The program is designed for medical, radiation, and surgical oncologists, gynecologists, radiologists, and primary care physicians. Other physician specialties, nurses, advanced practice clinicians, and healthcare professionals involved in the treatment of patients with breast cancer may find the program beneficial.
Accreditation Statement
The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.
Designation Statement
The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.
Disclosure Policy
It is the policy of the Temple Health Office for Continuing Medical Education to ensure that all sponsored continuing medical education activities are independently designed and produced and include content that is valid, objective, balanced, free of commercial bias and in the best interest to the public. Temple Health policy requires everyone in a position to control the content of an educational activity to disclose all financial relationships with ineligible companies and to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Temple Health Office for Continuing Medical Education has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to the activity.
Inquiries
Lucía Tono, PhD, Med: 215-728-3797
Lucia.Tono-Ramirez@tuhs.temple.edu